No Data
No Data
KPC Pharmaceuticals, Inc. (600422.SH): Currently, it has formed three major product matrices of plant skin care, oral care, and health preservation.
On July 24th, Gelunhui Investors asked a question to KPC Pharmaceuticals, Inc. (600422.SH) on the Investor Interaction Platform, "What measures does your company plan to take to expand its toothpaste and personal care product sector?" The company replied that KPC Health is based on the company's core characteristic plant resources, such as Sanqi, Qinghao, Tianma, Licorice, etc. and continuously creates products with more efficiency around innovative research and development technology. Currently, it has formed three major product sectors, namely Plant Skin Care, Oral Care, and Health Maintenance. The health sector is currently exploring the development of technology support and competitive barriers from channel marketing to R&D, and building the foundation for the future development of KPC Health.
KPC Pharmaceuticals, Inc. (600422.SH) has no plans to launch health wine.
KPC Pharmaceuticals, Inc. (600422.SH) stated on the investor interactive platform on July 23 that the company currently has no plans to launch health wine.
KPC Pharmaceuticals, Inc. (600422.SH) annual equity distribution in 2023: dividend of 0.20 yuan per share, with stock rights registration on July 30th.
KPC Pharmaceuticals, Inc. (600422.SH) announced the implementation of annual equity distribution for 2023, and the profit distribution this time will be carried out in the form of...
KPC Pharmaceuticals, Inc. focuses on chronic disease management and opens a new chapter in global strategy for elderly health.
Event: The academic seminar on chronic disease management and the Member Representative Conference of the Geriatrics and Geriatric Medicine Society of China's Elderly Chronic Disease Management Branch were successfully held in Peking on June 22, 2024. KPC Pharmaceuticals, Inc. and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. were co-organizers of this conference.
First coverage report on KPC Pharmaceuticals, Inc. (600422): Empowering by China Resources to create a leader in the silver economy.
China Resources Sanjiu Medical & Pharmaceutical will lead the silver hair health industry by acquiring Kunyu Pharmaceutical in 2023, successfully completing the hundred-day and one-year integration: 1) The core management team and board of directors and supervisors were reorganized smoothly; 2) Connected with Sanjiu Commercial Road and empowered channel construction.
KPC Pharmaceuticals, Inc. (600422): Empowered by CR to Become the Leading Company in the Silver Economy.
Investment Highlights: China Resources has taken over and empowered to build the leading company in the silver economy. After the "hundred-day integration" and "one-year integration" period, the two companies have now entered the "three-year integration" phase. The hundred-day integration phase: 1. Continuous major moves, China Resources related executives at the helm.
No Data